Zhejiang Jingxin Pharmaceutical (002020.SZ) plans to spend 200 million to 400 million yuan to implement a share buyback. The repurchase price will not exceed 14.8 yuan per share.

Zhejiang Jingxin Pharmaceutical (002020.SZ) announced that the company plans to use its own funds to repurchase company shares through centralized bidding trading. The repurchased shares will be used for equity incentives or employee stock ownership plans. The total amount of the repurchase will be no less than RMB 200 million (including) and no more than RMB 400 million (including), with a repurchase price not exceeding RMB 14.8 per share (including). The implementation period of the share repurchase will be within 12 months from the date of approval by the board of directors of the repurchase plan.